Joint Continental Situation Report on the Mpox Epidemic in Africa (23 September- 03 November 2024)
1. Key Highlights in the last 28 days Notable trends in epidemiology, surveillance and containment • The epidemic is not yet contained as additional Member States continue to report outbreaks, driven by clade Ib. • Burundi weekly suspected cases are plateauing, with some fluctuations but the level of transmission remains relatively high. • Liberia had […]
Mpox Joint Africa CDC – WHO SITREP
Executive Summary Summary of major developments during the reporting period (e.g., significant outbreaks, policy changes, vaccination campaigns, etc.). • Africa CDC and WHO established a Technical Review Committee (TRC) as an access and allocation mechanism for mpox vaccines, treatments, and diagnostics. • Nigeria was the first country to receive 10,000 doses of the JYNNEOS mpox […]
Mpox Molecular Diagnostic Tests(RT-PCR)
On 13 August 2024, Africa Centres for Disease Control and Prevention (Africa CDC) declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS). The World Health Organization (WHO) followed this the next day, which extended the alert internationally as a Public Health Emergency of International Concern (PHEIC). After these declarations, many countries […]
Mpox Sequencing in Africa
Spread of Clade 1 Mpox Situation Summary Mpox virus (MPXV) is a member of the Orthopoxvirus genus. Symptoms typically include fever, skin rash, fatigue, and swollen lymph nodes. Severe cases can lead to complications such as pneumonia and encephalitis. As of 31 August 2024, more than 24,873 cases (5,549 confirmed cases) Mpox cases and 643 […]
Mpox Continental Preparedness and Response Plan for Africa
Executive Summary On August 13, 2024, the Africa CDC declared the mpox outbreak a Public Health Emergency of Continental Security (PHECS). The following day, the WHO declared it a Public Health Emergency of International Concern (PHEIC). A coordinated, continent-wide response is essential, co-led by the African Union (AU) through the Africa CDC and the World […]
Mpox Surveillance Reporting Protocol for African Union Member States
Introduction Mpox is a zoonotic infectious disease caused by the monkeypox virus (MPXV). The disease presents symptoms similar to smallpox but with lesser severity. The first human case of mpox was recorded in 1970 in the Democratic Republic of the Congo (DRC) and has subsequently been recognized as an endemic disease in several central and […]
Mpox Molecular Diagnostic Tests(RT-PCR)
RECOMMENDATIONS AS PER 13 AUGUST 2024 On 13 August 2024, Africa Centres for Disease Control and Prevention (Africa CDC) declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS). This was followed the next day by the World Health Organization (WHO), which extended the alert internationally as a public health emergency of […]
Mpox Technical Factsheet
What is mpox? Mpox is a zoonotic disease caused by a double-stranded DNA virus that belongs to the Orthopoxvirus genus of the Poxviridae family. The disease presents with symptoms similar to smallpox but with a lesser severity. It was first discovered in 1958 when two outbreaks of a poxlike disease occurred in colonies of monkeys […]
Explainer – Declaration of Public Health Emergency of Continental Security
1. What is the current situation of the Mpox outbreak in Africa? 2. Why declare it a Public Health Emergency of Continental Security? The declaration of Mpox as a Public Health Emergency of Continental Security by Africa CDC is a strategic decision to strengthen the collective and coordinated response to the outbreak across the continent. […]
Explicatif – Déclaration d’Urgence Sanitaire de Sécurité Continentale
Quelle est la situation actuelle de l’épidémie de variole de singe en Afrique ? 17 541 cas de Mpox dont 517 décès ont été reportés dans 12 pays africains en 2024: 1 en Afrique australe : Afrique du Sud 3 Afrique de l’Est : Kenya, Rwanda, Ouganda 5 en Afrique centrale : RDC, Burundi, RCA, Congo Brazza, Cameroun […]